Oleclumab for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Aug 2018: Trial registered, NCT03616886
  2. 28 Dec 2018: Trial started, NCT03616886

The trials

NCT03616886: Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC

State
Under way
Phase
Phase 1 and Phase 2
People
129 taking part
Started
28 Dec 2018
Primary completion
21 May 2021
Arms
Phase I and Phase II Arm A
Results
None posted
  1. 6 Aug 2018: Trial registered
  2. 28 Dec 2018: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.